Profile for European Patent Office Patent: 2086504
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for European Patent Office Patent: 2086504
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| 8,252,838 | Apr 21, 2028 | Horizon | PENNSAID | diclofenac sodium |
| 8,563,613 | Oct 17, 2027 | Horizon | PENNSAID | diclofenac sodium |
| 8,871,809 | Oct 17, 2027 | Horizon | PENNSAID | diclofenac sodium |
| 9,066,913 | Oct 17, 2027 | Horizon | PENNSAID | diclofenac sodium |
| 9,101,591 | Oct 17, 2027 | Horizon | PENNSAID | diclofenac sodium |
| 9,168,304 | Oct 17, 2027 | Horizon | PENNSAID | diclofenac sodium |
| 9,168,305 | Oct 17, 2027 | Horizon | PENNSAID | diclofenac sodium |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
